Cargando…

A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan

Background: The Standards for the Establishment of Universities in Japan were revised; subsequently, the number of schools or universities of pharmacy/pharmaceutical sciences increased from 46 in 2002 to 74 in 2016.The pharmacy education programme was also changed from four to six years, which was i...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Kayoko, Arakawa, Naoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838897/
https://www.ncbi.nlm.nih.gov/pubmed/33396226
http://dx.doi.org/10.3390/pharmacy9010006
_version_ 1783643285883977728
author Takeda, Kayoko
Arakawa, Naoko
author_facet Takeda, Kayoko
Arakawa, Naoko
author_sort Takeda, Kayoko
collection PubMed
description Background: The Standards for the Establishment of Universities in Japan were revised; subsequently, the number of schools or universities of pharmacy/pharmaceutical sciences increased from 46 in 2002 to 74 in 2016.The pharmacy education programme was also changed from four to six years, which was implemented in 2006. In this study, we provide the comparative results of the first cycle of the third-party accrediting organization, the Japan Accreditation Board for Pharmaceutical Education (JABPE); Methods: The results of the first cycle of all universities or schools of pharmacy assessed by the JABPE from JABPE website were retrieved, and we collated and compared the results based on the 13 areas of the assessment standards; Results: In “improvements”, the number of public universities or schools was less than that of private universities or schools, and the number of old private universities or schools was also less than the number of new private universities or schools in all assessment areas. Conclusions: These results suggest that new universities or schools established since 2003 have not yet established their own quality assurance mechanism within the institutions. We need to review the Japanese pharmacy education system or the assessment criteria for it to bring about essential change.
format Online
Article
Text
id pubmed-7838897
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78388972021-01-28 A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan Takeda, Kayoko Arakawa, Naoko Pharmacy (Basel) Case Report Background: The Standards for the Establishment of Universities in Japan were revised; subsequently, the number of schools or universities of pharmacy/pharmaceutical sciences increased from 46 in 2002 to 74 in 2016.The pharmacy education programme was also changed from four to six years, which was implemented in 2006. In this study, we provide the comparative results of the first cycle of the third-party accrediting organization, the Japan Accreditation Board for Pharmaceutical Education (JABPE); Methods: The results of the first cycle of all universities or schools of pharmacy assessed by the JABPE from JABPE website were retrieved, and we collated and compared the results based on the 13 areas of the assessment standards; Results: In “improvements”, the number of public universities or schools was less than that of private universities or schools, and the number of old private universities or schools was also less than the number of new private universities or schools in all assessment areas. Conclusions: These results suggest that new universities or schools established since 2003 have not yet established their own quality assurance mechanism within the institutions. We need to review the Japanese pharmacy education system or the assessment criteria for it to bring about essential change. MDPI 2020-12-31 /pmc/articles/PMC7838897/ /pubmed/33396226 http://dx.doi.org/10.3390/pharmacy9010006 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Takeda, Kayoko
Arakawa, Naoko
A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan
title A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan
title_full A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan
title_fullStr A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan
title_full_unstemmed A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan
title_short A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan
title_sort comparative exploration of quality assurance results by the third-party pharmaceutical education evaluation in japan
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838897/
https://www.ncbi.nlm.nih.gov/pubmed/33396226
http://dx.doi.org/10.3390/pharmacy9010006
work_keys_str_mv AT takedakayoko acomparativeexplorationofqualityassuranceresultsbythethirdpartypharmaceuticaleducationevaluationinjapan
AT arakawanaoko acomparativeexplorationofqualityassuranceresultsbythethirdpartypharmaceuticaleducationevaluationinjapan
AT takedakayoko comparativeexplorationofqualityassuranceresultsbythethirdpartypharmaceuticaleducationevaluationinjapan
AT arakawanaoko comparativeexplorationofqualityassuranceresultsbythethirdpartypharmaceuticaleducationevaluationinjapan